Medianen for det primære endepunkt, progressionsfri overlevelse, var 40 måneder i R- FC- gruppen og 32 måneder i FC- gruppen (p < 0, 0001, log- rank test).
The primary endpoint of progression-free survival was 40 months in median in the R-FC group and 32 months in the FC group (p < 0.0001, log-rank test).